Next-generation sequencing instruments no longer need to be limited to their immediate labs and institutions. With Meenta, you can find and submit projects to thousands of shared sequencing equipment and services.Sign In
At Meenta we decided to make every single scientific instrument in the world accessible. We believe that in the future accessing scientific equipment will be as easy as spinning up CPU time in the cloud.
Efforts to accelerate research have thus far focused on making scientific instruments faster and cheaper. However, these advances cannot be fully realized because the infrastructure required to access these technologies simply do not exist. It's as if science has created supercomputers without the internet! We know this problem because we've lived it. That is why we decided to create the infrastructure on which science can be scaled and would make previously thought of fixed assets liquid.
Gabor has 20 years of business expertise in the area of genomics and diagnostics spanning some of the best companies in the field including Agilent Technologies and Roche Diagnostics. As founder and Chief Commercial Officer of Parabase Genomics he built the company from the ground up creating the first commercial play in the field of Neonatal Precision Medicine.Read More Read Less keyboard_arrow_right
Boston based entrepreneur and full stack developer with extensive web, mobile, and systems design and development experience. Has extensive experience building development teams, system architecture and managing software through the planning, development and deployment.Read More Read Less keyboard_arrow_right
Torrey is Director of Product and a Co-Founder at Meenta. She has worked in global health economics at the Harvard Medical School, WHO, and is a former Peace Corps Volunteer. She holds a master's degree in global development, International public health from Boston University.Read More Read Less keyboard_arrow_right
Kirk is a board-certified Family Practice Physician. He studied at the Saint Louis University School of Medicine and completed his residency at the Mayo Clinic (Rochester, Minnesota). He served as a Flight Surgeon for the U.S. Air Force at MacDill Air Force Base for 4 years. He is a medical entrepreneur, interested in bringing high-quality care and treatments to previously under-served populations, and is currently serving as Meenta's Chief Medical Officer, where he is responsible for providing patient follow up as well as medical and regulatory oversight for all testing services.
Dana has 20 years of commercialization success in Diagnostics and Biotechnology applying in-depth technical knowledge of molecular genetics and clinical informatics to deliver innovative solutions that address unmet customer needs, and is now responsible for developing and executing the commercial strategy at Meenta.
Kyle has extensive research expertise and interest in the area of genomics, microbiology and immunology. He received his Ph.D. from the University of Maryland, Baltimore working at the Institute for Genome Sciences and came to Meenta from a postdoc at Yale University.Read More Read Less keyboard_arrow_right
Dr. Leach is an executive leader, scientist, and entrepreneur. Through his career, he has acquired domain expertise in human genomics, big data, A.I., reproductive medicine, aerospace, manufacturing, corporate strategy, and business development. Demonstrating the ability to lead from concept through delivery, Dr. Leach has chaperoned fundamental technologies with and without established applications to successful business endpoints by guiding company architecture, market development and commercialization. Some of his previous roles include Chief Commercial Officer at WuXi NextCode Genomics, Vice President at Complete Genomics, Vice President at deCODE Genetics, and Chief Science Officer and Founder at Teneo Sciences. While at those companies, Dr. Leach created business strategies and successfully led the implementation of genetic analysis technologies for research and clinical diagnostic applications in multiple geopolitical environments. With significant involvement in population-specific and nation-scale discovery biology programs, he has led successful business opportunities in 28 countries around the world. In addition to this, he has gained high-level governance experience during service on several Boards of Directors. Today, Dr. Leach is the Chief Strategy Officer for the International Space Station U.S. National Laboratory, spearheading Low Earth Orbit commercialization by developing a portfolio of basic and applied research programs in public-private partnerships.
Dr. Leach holds a B.S. degree in Biology from Hillsdale College, a Ph.D. in Molecular Biology from Ohio University, was a Fellow in the Division of Experimental Therapeutics at Walter Reed Army Institute of Research for the US Department of Defense and was a Visiting Fellow at the National Cancer Institute of the National Institutes of Health.
Cory von Wallenstein is the former CTO at Dyn (acquired by Oracle) and a full time early stage investor and advisor. He's shared his learnings writing for Wired, HuffPost, Inc., TechCrunch, Forbes, as a guest speaker at LAUNCH, Interop, Structure, CIO Summit, and as a guest lecturer at WPI, MIT and Harvard.Read More Read Less keyboard_arrow_right
Andrei Hagiu is a Visiting Associate Professor of Technological Innovation, Entrepreneurship, and Strategic Management at the MIT Sloan School of Management since July 2016. Previously, he was an Associate Professor in the Strategy group at Harvard Business School. In 2012, he took a leave of absence from Harvard in order to work full-time at Intuit, helping with its strategic transformation from a product-focused company into a platform company. Andrei holds a PhD in economics from Princeton University and did his undergraduate studies at the Ecole Polytechnique in France. He is a citizen of Romania, France and the United States.
Andrei’s research focuses on multi-sided platforms (e.g. Airbnb, Amazon, eBay, Google, Facebook, PlayStation, TaskRabbit, etc.) and their unique strategic challenges. His work has been published in the Rand Journal of Economics, Management Science, Journal of Economic Perspectives, Journal of Economics & Management Strategy, and the Harvard Business Review. Andrei serves as a Co-Editor for the Journal of Economics & Management Strategy. At Harvard Business School, Andrei teaches the Strategy & Technology elective course in the MBA program.
On the consulting side, Andrei works with both startups attempting to build multi-sided platform businesses and large companies seeking to turn products into multi-sided platforms. He is on the board of advisors of CoachUp, a marketplace connecting users with sports coaches for private lessons.
Kevin Novak is an experienced data science leader and advisor, as well as an active investor and entrepreneur. In his career, he has served as Head of Data Science at Uber and Chief Data Officer at Tala Financial, as well as serving as an advisor to Standard Cognition and Meenta. He is considered an expert in dynamic pricing, marketplace design, and data science hiring and organizational design.Read More Read Less keyboard_arrow_right
Robert Steen is the director of Harvard Medical School’s genomics core facility located within the Department of Genetics in the Longwood Medical Area of Boston. He directs a team of scientists that provide a wide variety of molecular biology services to the faculty at HMS and its sixteen affiliate hospitals and research institutes. Robert has expertise in technology evaluation, process optimization, production oversite, team management and data quality analysis. His core currently focuses on sample preparation and next-generation sequencing for a wide variety of scientific applications. He has over 17 years of experience directing core facilities, three years as director of the HHMI genetics core at HMS and 14 years as current director of the genomics core within the department of genetics at HMS.
In the nine years prior to serving as a core director, Robert worked on and later managed various teams under the direction of Dr. Eric Lander and Dr. Thomas Hudson at the Whitehead Institute/MIT Center for Genome Research, constructing the first comprehensive, genome-wide genetic maps of the mouse and rat. From 1988 to 1991 Robert conducted research on the origins of HIV and SIV in the department of microbiology and molecular genetics at the New England Regional Primate Research Center at Harvard Medical School.
Dr. Stacey Gabriel is a human geneticist, with a research interest in large-scale genomics and its application to human medical genetics research. She is currently an Institute Scientist and Senior Director of the Broad Institute’s Genomics Platform one of the largest sequencing centers in the world. She oversees the125-person organization that encompasses all production and development activities related to sample handling, sequencing, gene expression, genotyping and related data processing and management activities.
Since joining the Broad Institute (formerly the Whitehead Institute Center for Genome Research), she has played central roles in the development of methods for generating and analyzing data using genotyping and next-generation sequencing in the setting of cancer and medical genetics studies.
Dr. Gabriel joined the Whitehead Institute/MIT Center for Genome Research working under the direction of Eric Lander in 1998. Gabriel received her B.S. in Molecular Biology from Carnegie Mellon University (1993) and Ph.D. in Human Genetics from Case Western Reserve University (1998).
Shawn Levy, PhD, is a faculty investigator and the founding director of the Genomic Services Laboratory (GSL) at the HudsonAlpha Institute for Biotechnology. He serves as executive director of the HudsonAlpha Clinical Services Laboratory, LLC., which he launched in 2014. Levy focuses on the development and application of genomic and bioinformatic technologies and methods to support scientific investigation. His team uses high performance genotyping and sequencing technologies to support projects from plant and animal phylogenetic studies to translational and clinical-based projectsat the GSL. Levy is adjunct faculty in the department of genetics and department of epidemiology at the University of Alabama at Birmingham and serves as an ad hoc reviewer for more than a dozen scientific journals. He received his PhD in biochemistry and completed a postdoctoral fellowship in genetics in 2000 at Emory University in Atlanta, where he set up a microarray facility at the Emory Center for Molecular Medicine. Before joining HudsonAlpha in 2009, Levy was a faculty member at Vanderbilt University Medical Center with appointments in the department of molecular physiology and biophysics and the department of biomedical informatics. He was the founding director of the Vanderbilt Microarray Shared Resource.Read More Read Less keyboard_arrow_right